Zhang Guoyu, Li Na, Li Zhu, Zhu Qianqian, Li Fang, Yang Cuiling, Han Qunying, Lv Yi, Zhou Zhihua, Liu Zhengwen
Department of Infectious Diseases, First Affiliated Hospital, School of Medicine, Xi'an Jiaotong University, Xi' an, Shaanxi, China.
Department of Hepatobiliary Surgery, First Affiliated Hospital, School of Medicine, Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Oncotarget. 2015 Aug 7;6(22):18933-44. doi: 10.18632/oncotarget.3662.
Programmed cell death-1 (PD-1) is involved in hepatitis B virus (HBV) infection, the leading cause of hepatocellular carcinoma (HCC) worldwide. Single-nucleotide polymorphism, rs10204525, located in the PD1 3' untranslated regions (UTR), is associated with chronic HBV infection. MicroRNAs (miRNAs) regulate gene expression via specific binding to the target 3'UTR of mRNA. In this study, three miRNAs were predicted to putatively interact with PD1 rs10204525 polymorphic site of allele G. One of them, miRNA-4717, was demonstrated to allele-specifically affect luciferase activity in a dose-dependent manner in cells transfected with vectors containing different rs10204525 alleles. In lymphocytes from chronic HBV patients withrs10204525 genotype GG, miR-4717 mimics significantly decreased PD-1 expression and increased (TNF)-α and interferon (IFN)-γ production. miR-4717 inhibitor significantly increased PD-1 expression and decreased TNF-α and IFN-γ production although not significantly. In lymphocytes from chronic HBV patients with rs10204525 genotype AA, no similar effects were observed. miR-4717 levels in peripheral lymphocytes from patients with HBV-related chronic hepatitis, cirrhosis and HCC were significantly decreased. In conclusion, miR-4717 may allele-specifically regulate PD-1 expression through interaction with the 3' UTR of PD1 mRNA, leading to the alteration of immune regulation and affecting the susceptibility and disease course of chronic HBV infection.
程序性细胞死亡蛋白1(PD-1)与乙型肝炎病毒(HBV)感染有关,HBV感染是全球肝细胞癌(HCC)的主要病因。位于PD1 3'非翻译区(UTR)的单核苷酸多态性rs10204525与慢性HBV感染相关。微小RNA(miRNA)通过与mRNA的靶标3'UTR特异性结合来调节基因表达。在本研究中,预测有三种miRNA可能与等位基因G的PD1 rs10204525多态性位点相互作用。其中一种,即miRNA-4717,在转染了含有不同rs10204525等位基因载体的细胞中,被证明以剂量依赖的方式等位基因特异性地影响荧光素酶活性。在rs10204525基因型为GG的慢性HBV患者的淋巴细胞中,miR-4717模拟物显著降低了PD-1表达,并增加了肿瘤坏死因子(TNF)-α和干扰素(IFN)-γ的产生。miR-4717抑制剂虽未显著增加PD-1表达,但显著降低了TNF-α和IFN-γ的产生。在rs10204525基因型为AA的慢性HBV患者的淋巴细胞中,未观察到类似效应。HBV相关慢性肝炎、肝硬化和HCC患者外周淋巴细胞中的miR-4717水平显著降低。总之,miR-4717可能通过与PD1 mRNA的3'UTR相互作用等位基因特异性地调节PD-1表达,导致免疫调节改变,并影响慢性HBV感染的易感性和病程。